Dr. Pieter Kappetein, MD, PhD, is a Consultant Cardiothoracic Surgeon, Professor and Chair of the residency program at the Thoraxcenter at the Erasmus Medical Centre in Rotterdam, The Netherlands. He is board certified in Cardiothoracic Surgery. His specialty is cardiothoracic surgery.
He is Secretary General of the European Association for Cardio-thoracic Surgery, President of CTSnet and member of the Board of the Society of Thoracic Surgeons and chairman of the International Cooperation committee of the STS in the USA.
Besides this he is member of the Editorial Board of the Annals of Thoracic Surgery and Deputy Editor of Eurointervention. His clinical interests include aortic valve surgery, indications, outcome; percutaneous aortic and mitral valve replacement and repair ; coronary surgery; outcome compared to DES; and new techniques in the field, education, and epidemiology.
He is co-principal investigator of the SYNTAX and EXCEL trial (comparing coronary surgery with drug eluting stents) and member of the steering committee of the REPRISE III and SURTAVI trial on percutaneous valves and the RESHAPE trial: the evaluation of the Mitraclip in patients with heart failure. He was also member of the steering committee of the Re-align trial on Dabigatran in patients with mechanical heart valves.
Interventional Cardiology Review 2013;9(1):37–40
Interventional Cardiology 2012:7(2):91-4
Interventional Cardiology 2011;6(1):71–5